根据该协议,Catalent将向TFF提供其扩大规模的专业知识和制造能力,作为其首选的开发和制造合作伙伴,Catalent将能够向其客户提供TFF技术,这有可能增加...查看全文
美港电讯APP2020-09-24 21:21
TFF制药(TFFP.O):在实验中,发现含亮氨酸的瑞德西韦干粉制剂能更持久地从肺释放到到血浆,公司正与吉利德科学(GILD.O)就此研究结果进行讨论。$TFF Pharmaceuticals(TFFP)$ $吉利德科学(GILD)$ (来自美港电讯APP)查看全文
chuminhua2020-08-14 10:55
8月13日,TFF Pharmaceuticals,Inc.$TFF Pharmaceuticals(TFFP)$ 是一家临床阶段的生物制药公司,专注于根据其专利的薄膜冷冻(TFF)技术平台开发和商业化创新药物产品,宣布已与UNION therapeutics签订了一项全球独家许可协议,将其TFF技术与氯硝柳胺(niclosamide)联合使用。根据协议条款,UNI...查看全文
$TFF Pharmaceuticals(TFFP)$ 内部交易: 2020-12-11,Director,MILLS ROBERT S ,期权,22794普通股, $2.50
$TFF Pharmaceuticals(TFFP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-20-042771 Size: 8 KB 网页链接
$TFF Pharmaceuticals(TFFP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-20-041813 Size: 8 KB 网页链接
$TFF Pharmaceuticals(TFFP)$ 内部交易: 2020-12-04,10% Owner,Lung Therapeutics, Inc. ,卖出,1050000普通股, $13.86
$TFF Pharmaceuticals(TFFP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-20-041606 Size: 7 KB 网页链接
$TFF Pharmaceuticals(TFFP)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001213900-20-041549 Act: 33 Size: 338 KB 网页链接
$TFF Pharmaceuticals(TFFP)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001213900-20-041151 Act: 33 Size: 341 KB 网页链接
$TFF Pharmaceuticals(TFFP)$ 8-K Current report, item 8.01 Accession Number: 0001213900-20-041152 Act: 34 Size: 23 KB 网页链接
$TFF Pharmaceuticals(TFFP)$ 8-K Current report, item 8.01 Accession Number: 0001213900-20-040944 Act: 34 Size: 21 KB 网页链接
$TFF Pharmaceuticals(TFFP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-20-039036 Size: 4 KB 网页链接